130 related articles for article (PubMed ID: 30109377)
1. Comparison of contrast-enhanced and diffusion-weighted MRI in assessment of the terminal ileum in Crohn's disease patients.
Puylaert CAJ; Tielbeek JAW; Schüffler PJ; Nio CY; Horsthuis K; Mearadji B; Ponsioen CY; Vos FM; Stoker J
Abdom Radiol (NY); 2019 Feb; 44(2):398-405. PubMed ID: 30109377
[TBL] [Abstract][Full Text] [Related]
2. Preoperative evaluation of small bowel complications in Crohn's disease: comparison of diffusion-weighted and contrast-enhanced MR imaging.
Barat M; Hoeffel C; Bouquot M; Jannot AS; Dautry R; Boudiaf M; Pautrat K; Kaci R; Camus M; Eveno C; Pocard M; Soyer P; Dohan A
Eur Radiol; 2019 Apr; 29(4):2034-2044. PubMed ID: 30302591
[TBL] [Abstract][Full Text] [Related]
3. Dynamic contrast-enhanced magnetic resonance imaging and diffusion-weighted imaging in the activity staging of terminal ileum Crohn's disease.
Wu YC; Xiao ZB; Lin XH; Zheng XY; Cao DR; Zhang ZS
World J Gastroenterol; 2020 Oct; 26(39):6057-6073. PubMed ID: 33132655
[TBL] [Abstract][Full Text] [Related]
4. Quantitative diffusion-weighted magnetic resonance enterography in ileal Crohn's disease: A systematic analysis of intra and interobserver reproducibility.
Yu H; Shen YQ; Tan FQ; Zhou ZL; Li Z; Hu DY; Morelli JN
World J Gastroenterol; 2019 Jul; 25(27):3619-3633. PubMed ID: 31367161
[TBL] [Abstract][Full Text] [Related]
5. Prospective comparison of diffusion-weighted magnetic resonance enterography and contrast enhanced computed tomography enterography for the detection of ileocolonic Crohn's disease.
Yu H; Wang Y; Wang Z; Li J; Lu J; Hu D
J Gastroenterol Hepatol; 2020 Jul; 35(7):1136-1142. PubMed ID: 31785602
[TBL] [Abstract][Full Text] [Related]
6. Comparison of MRI Activity Scoring Systems and Features for the Terminal Ileum in Patients With Crohn Disease.
Puylaert CAJ; Nolthenius CJT; Tielbeek JAW; Makanyanga JC; Rodriguez-Justo M; Brosens LAA; Nio CY; Pendsé DA; Ponsioen CY; Vos FM; Taylor SA; Stoker J
AJR Am J Roentgenol; 2019 Feb; 212(2):W25-W31. PubMed ID: 30540212
[TBL] [Abstract][Full Text] [Related]
7. IVIM with fractional perfusion as a novel biomarker for detecting and grading intestinal fibrosis in Crohn's disease.
Zhang MC; Li XH; Huang SY; Mao R; Fang ZN; Cao QH; Zhang ZW; Yan X; Chen MH; Li ZP; Sun CH; Feng ST
Eur Radiol; 2019 Jun; 29(6):3069-3078. PubMed ID: 30547200
[TBL] [Abstract][Full Text] [Related]
8. Impact of gadolinium-based contrast agent in the assessment of Crohn's disease activity: Is contrast agent injection necessary?
Quaia E; Sozzi M; Gennari AG; Pontello M; Angileri R; Cova MA
J Magn Reson Imaging; 2016 Mar; 43(3):688-97. PubMed ID: 26250897
[TBL] [Abstract][Full Text] [Related]
9. Semiautomatic Assessment of the Terminal Ileum and Colon in Patients with Crohn Disease Using MRI (the VIGOR++ Project).
Puylaert CAJ; Schüffler PJ; Naziroglu RE; Tielbeek JAW; Li Z; Makanyanga JC; Tutein Nolthenius CJ; Nio CY; Pendsé DA; Menys A; Ponsioen CY; Atkinson D; Forbes A; Buhmann JM; Fuchs TJ; Hatzakis H; van Vliet LJ; Stoker J; Taylor SA; Vos FM
Acad Radiol; 2018 Aug; 25(8):1038-1045. PubMed ID: 29428210
[TBL] [Abstract][Full Text] [Related]
10. The added value of PET/Ce-CT/DW-MRI fusion in assessment of hepatic focal lesions: PET/Ce-CT/DW-MRI fusion in hepatic focal lesion.
Salem S; Houseni M; Zidan L; Kandil A
Nucl Med Biol; 2015 Jul; 42(7):637-42. PubMed ID: 25907467
[TBL] [Abstract][Full Text] [Related]
11. Influence of diffusion weighted imaging and contrast enhanced T1 sequences on the diagnostic accuracy of magnetic resonance enterography for Crohn's disease.
Bhatnagar G; Mallett S; Beable R; Greenhalgh R; Ilangovan R; Lambie H; Mainta E; Patel U; Porté F; Sidhu H; Gupta A; Higginson A; Slater A; Tolan D; Zealley I; Halligan S; Taylor SA;
Eur J Radiol; 2024 Jun; 175():111454. PubMed ID: 38598964
[TBL] [Abstract][Full Text] [Related]
12. Can diffusion-weighted magnetic resonance imaging (DW-MRI) alone be used as a reliable sequence for the preoperative detection and characterisation of hepatic metastases? A meta-analysis.
Wu LM; Hu J; Gu HY; Hua J; Xu JR
Eur J Cancer; 2013 Feb; 49(3):572-84. PubMed ID: 23000072
[TBL] [Abstract][Full Text] [Related]
13. Diffusion-weighted magnetic resonance imaging in ileocolonic Crohn's disease: validation of quantitative index of activity.
Hordonneau C; Buisson A; Scanzi J; Goutorbe F; Pereira B; Borderon C; Da Ines D; Montoriol PF; Garcier JM; Boyer L; Bommelaer G; Petitcolin V
Am J Gastroenterol; 2014 Jan; 109(1):89-98. PubMed ID: 24247212
[TBL] [Abstract][Full Text] [Related]
14. Contrast enhanced magnetic resonance imaging of the terminal ileum in children with Crohn's disease.
Laghi A; Borrelli O; Paolantonio P; Dito L; Buena de Mesquita M; Falconieri P; Passariello R; Cucchiara S
Gut; 2003 Mar; 52(3):393-7. PubMed ID: 12584222
[TBL] [Abstract][Full Text] [Related]
15. Which combination of MR imaging modalities is best for predicting recurrent glioblastoma? Study of diagnostic accuracy and reproducibility.
Kim HS; Goh MJ; Kim N; Choi CG; Kim SJ; Kim JH
Radiology; 2014 Dec; 273(3):831-43. PubMed ID: 24885857
[TBL] [Abstract][Full Text] [Related]
16. Diffusion-weighted MRI: role in detecting abdominopelvic internal fistulas and sinus tracts.
Schmid-Tannwald C; Agrawal G; Dahi F; Sethi I; Oto A
J Magn Reson Imaging; 2012 Jan; 35(1):125-31. PubMed ID: 21953793
[TBL] [Abstract][Full Text] [Related]
17. Renal lesions: characterization with diffusion-weighted imaging versus contrast-enhanced MR imaging.
Taouli B; Thakur RK; Mannelli L; Babb JS; Kim S; Hecht EM; Lee VS; Israel GM
Radiology; 2009 May; 251(2):398-407. PubMed ID: 19276322
[TBL] [Abstract][Full Text] [Related]
18. Diagnosis of postoperative recurrence of Crohn disease with MR-enterography: Value of diffusion-weighted imaging.
Djelouah M; Marical V; Kanagaratnam L; Kianmanesh R; Biron A; Cadiot G; Hoeffel C
Diagn Interv Imaging; 2021 Dec; 102(12):743-751. PubMed ID: 34154981
[TBL] [Abstract][Full Text] [Related]
19. Grading Crohn disease activity with MRI: interobserver variability of MRI features, MRI scoring of severity, and correlation with Crohn disease endoscopic index of severity.
Tielbeek JA; Makanyanga JC; Bipat S; Pendsé DA; Nio CY; Vos FM; Taylor SA; Stoker J
AJR Am J Roentgenol; 2013 Dec; 201(6):1220-8. PubMed ID: 24261360
[TBL] [Abstract][Full Text] [Related]
20. Usefulness of diffusion-weighted imaging and dynamic contrast-enhanced magnetic resonance imaging in the diagnosis of prostate transition-zone cancer.
Yoshizako T; Wada A; Hayashi T; Uchida K; Sumura M; Uchida N; Kitagaki H; Igawa M
Acta Radiol; 2008 Dec; 49(10):1207-13. PubMed ID: 19031184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
